Fuller & Thaler Asset Management’s ResMed RMD Stock Holding History

Fuller & Thaler Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$435K	Sell	2,233 -5	-0.2%	-$1.04K	﹤0.01%	461
2026 Q1	$502K	Hold	2,238	–	–	﹤0.01%	427
2025 Q4	$539K	Hold	2,238	–	–	﹤0.01%	433
2025 Q3	$613K	Hold	2,238	–	–	﹤0.01%	414
2025 Q2	$577K	Buy	2,238 +605	+37%	+$144K	﹤0.01%	421
2025 Q1	$366K	Hold	1,633	–	–	﹤0.01%	475
2024 Q4	$373K	Sell	1,633 -217	-12%	-$52.2K	﹤0.01%	487
2024 Q3	$452K	Sell	1,850 -1,580	-46%	-$353K	﹤0.01%	455
2024 Q2	$657K	Buy	+3,430	New	+$696K	﹤0.01%	450
2016 Q3	–	Sell	-500	Closed	-$32K	–	827
2016 Q2	$32K	Hold	500	–	–	﹤0.01%	652
2016 Q1	$29K	Sell	500 -2,400	-83%	-$136K	﹤0.01%	644
2015 Q4	$156K	Hold	2,900	–	–	﹤0.01%	417
2015 Q3	$148K	Buy	+2,900	New	+$156K	﹤0.01%	426
2013 Q3	–	Sell	-3,100	Closed	-$140K	–	713
2013 Q2	$140K	Buy	+3,100	New	+$147K	0.01%	409

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Fuller & Thaler Asset Management's RMD Position: Q2 2026 in Review

Fuller & Thaler Asset Management reduced its ResMed (RMD) stake by 0.22% in Q2 2026, selling an estimated $1.04K and leaving 2,233 shares worth $435K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

Fuller & Thaler Asset Management first reported a position in RMD in Q2 2013 and has held it in 14 quarters since. The position peaked at $657K in Q2 2024. 707 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Fuller & Thaler Asset Management held 2,233 shares of ResMed worth $435K as of Q2 2026.
Fuller & Thaler Asset Management sold 5 ResMed shares in Q2 2026, an estimated $1.04K.
ResMed made up ﹤0.01% of Fuller & Thaler Asset Management's portfolio in Q2 2026, its #461 holding.
Fuller & Thaler Asset Management first reported a position in ResMed in Q2 2013 and has held it in 14 quarters since.
Fuller & Thaler Asset Management's ResMed position peaked at $657K in Q2 2024.
707 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.